BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 13, 2009
View Archived Issues
Phase II data disclosed for ABT-869 in the treatment of RCC and HCC
Read More
New atypical antipsychotic JNJ-37822681 enters phase II trial in schizophrenia
Read More
RESOLVE results: improved visual acuity in diabetic macular edema with ranibizumab
Read More
Benefit of phentermine/topiramate seen in type 2 diabetes patients in phase II trial
Read More
Pooled analysis shows saxagliptin beneficial in elderly type 2 diabetes patients
Read More
Prospective analysis supports triamcinolone acetonide in Hunner's ulcer subtype IC
Read More
Recent study supports use of alfuzosin in primary bladder neck obstruction
Read More
GPC Biotech provides update on merger with Agennix
Read More
Lpath reports phase I results for iSONEP in patients with wet AMD
Read More
Nerviano Medical Sciences reports results from phase I danusertib trial
Read More
NeuroSearch begins phase Ib ACR-325 study in Parkinson's disease dyskinesias
Read More
New compounds for the treatment of obesity claimed by University of Strathclyde
Read More
Novel TpoR agonists in early development at Shanghai Hengrui
Read More
Epigenomics initiates testing of mSEPT9 in plasma samples collected in PRESEPT study
Read More
AC Immune to utilize Bayer's florbetaben in phase I trial of AD vaccine ACI-24
Read More
AstraZeneca describes VLA-5 antagonists for the treatment of cancer
Read More
RXi Pharmaceuticals presents preclinical results from animal studies of sd-rxRNA
Read More
Plexxikon initiates dosing in phase I trial of first-in-class cancer drug PLX-3397
Read More
FDA advisory committee recommends approval of Pfizer's Selzentry in HIV
Read More
CardioPharma plans to submit NDA for CardiaPill polypill
Read More
Ipsen granted manufacturing, marketing and distribution rights to Braintree's BLI-800
Read More
MediGene completes recruitment in phase II trial of EndoTAG in breast cancer
Read More
Actelion initiates phase IIb study of ACT-128800 in multiple sclerosis
Read More
FDA issues complete response letter for Spectrum's sNDA for Fusilev
Read More
MacuCLEAR and Mystic complete phase Ib trial of MC-1101 in AMD
Read More